Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Boman

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Cancer|September 10, 1998
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesisB G Sorbe, A M Berglind, H Andersson, et al.
Coronary Artery Disease|April 3, 2001
Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern SwedenA M Thögersen, T K Nilsson, G Dahlen, et al.
Archives of Dermatological Research|January 1, 1992
Interleukin-6 in psoriasis: expression and mitogenicity studiesJ T Elder, C I Sartor, D K Boman, et al.
Circulation|November 24, 1998
High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factorA M Thögersen, J H Jansson, K Boman, et al.
Journal of Internal Medicine|May 5, 1998
Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from northern SwedenL Weinehall, O Johnson, J H Jansson, et al.
British Journal of Cancer|May 9, 2013
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancerK Boman, A H Larsson, U Segersten, et al.
Journal of Human Hypertension|March 26, 2004
Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE studyJ Kontos, V Papademetriou, K Wachtell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 22, 2011
Impact of overweight and obesity on cardiac benefit of antihypertensive treatmentE Gerdts, G de Simone, B P Lund, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Antianginal effect of conventional and controlled release diltiazem in stable angina pectorisK Boman, H Saetre, L G Karlsson, et al.
Journal of Hypertension|August 23, 2000
Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertensionR B Devereux, M J Roman, V Palmieri, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cancer|September 10, 1998
A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesisB G Sorbe, A M Berglind, H Andersson, et al.
Coronary Artery Disease|April 3, 2001
Homozygosity for the C677-->T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern SwedenA M Thögersen, T K Nilsson, G Dahlen, et al.
Archives of Dermatological Research|January 1, 1992
Interleukin-6 in psoriasis: expression and mitogenicity studiesJ T Elder, C I Sartor, D K Boman, et al.
Circulation|November 24, 1998
High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factorA M Thögersen, J H Jansson, K Boman, et al.
Journal of Internal Medicine|May 5, 1998
Perceived health modifies the effect of biomedical risk factors in the prediction of acute myocardial infarction. An incident case-control study from northern SwedenL Weinehall, O Johnson, J H Jansson, et al.
British Journal of Cancer|May 9, 2013
Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancerK Boman, A H Larsson, U Segersten, et al.
Journal of Human Hypertension|March 26, 2004
Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE studyJ Kontos, V Papademetriou, K Wachtell, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 22, 2011
Impact of overweight and obesity on cardiac benefit of antihypertensive treatmentE Gerdts, G de Simone, B P Lund, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Antianginal effect of conventional and controlled release diltiazem in stable angina pectorisK Boman, H Saetre, L G Karlsson, et al.
Journal of Hypertension|August 23, 2000
Left ventricular wall stresses and wall stress-mass-heart rate products in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint reduction in hypertensionR B Devereux, M J Roman, V Palmieri, et al.
Pageof 11